We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ECL Boosts High-Tech Water Platform With Ovivo's Electronics Business
Read MoreHide Full Article
Key Takeaways
ECL closed the Ovivo Electronics deal, expanding its high-tech water platform.
ECL adds Ovivo's ultrapure water expertise to enhance circular water solutions for chip manufacturing.
The acquisition is set to more than double ECL's high-tech water business with strong long-term growth.
Ecolab (ECL - Free Report) recently closed its previously announced acquisition of Ovivo’s Electronics business, a fast-growing global provider of ultrapure water technologies used in semiconductor manufacturing. The deal meaningfully expands Ecolab’s presence in the high-tech water solutions space, positioning it to serve customers across the semiconductor value chain as demand accelerates from AI, advanced computing and data center investments.
By combining Ovivo Electronics’ ultrapure water expertise with Ecolab’s global water, digital and service capabilities, the company strengthens its water circularity offering in one of the most water-intensive industries.
Likely Trend of ECL Stock Following the News
Following the announcement, the company's shares traded flat in yesterday’s after-market trading. In the six-month period, shares have gained 0.6% against the industry’s 2.8% decline. The S&P 500 has gained 16.2% in the same time frame.
Over the long term, the Ovivo Electronics acquisition should strengthen Ecolab’s growth and margin profile by deepening its presence in the fast-growing semiconductor and AI ecosystem. Ultrapure water is mission-critical for chip manufacturing and combining Ovivo’s technologies with ECL’s global water, digital and service platform enables more comprehensive, end-to-end solutions, higher customer retention and recurring service revenues.
ECL currently has a market capitalization of $73.51 billion. In the last reported quarter, ECL delivered an earnings surprise of 0.49%.
Image Source: Zacks Investment Research
More on the Acquisition News
In August, Ecolab entered into a definitive agreement to acquire Ovivo’s Electronics business. Ovivo Electronics is expected to generate around $500 million in sales in 2025 and employs more than 900 people worldwide. ECL acquired the business for approximately $1.8 billion in cash, subject to customary adjustments. Strategically, the deal brings together Ovivo’s ultra-pure water capabilities with ECL’s established water solutions, digital technologies and global service network, enabling it to offer end-to-end circular water management solutions for microelectronics customers while helping reduce fresh water consumption and improve chip yield and quality.
Management highlighted that ultra-pure water is essential for advanced chip manufacturing, with a single semiconductor fab capable of consuming the annual drinking water needs of about 17 million people, underscoring the importance of sustainable water solutions. The acquisition is expected to more than double ECL’s global high-tech water growth engine, positioning the combined $800 million high-tech business for strong double-digit growth and attractive operating margins. Financially, the transaction is anticipated to be immediately accretive to sales growth, neutral to adjusted EPS in the first-year post-close, excluding roughly $45 million in non-cash amortization, and increasingly accretive through 2027 and beyond.
Favorable Industry Prospects for ECL
Per a report by Future Market Insights, the ultrapure water market is estimated to be valued at $10.9 billion in 2025 and projected to reach $31.1 billion by 2035, registering a CAGR of 11.1% over the forecast period.
The ultrapure water market is expanding steadily, owing to rising demand from industries where water purity is critical for operations such as semiconductor manufacturing, pharmaceuticals and power generation.
Other Recent Developments for ECL
In November, ECL expanded its data-center-focused portfolio with the launch of a fully integrated Cooling as a Service program designed to elevate cooling performance from site to chip. Arriving at a time when AI-driven workloads are rapidly intensifying demand on global data center infrastructure, the new offering combines Ecolab’s 3D TRASAR technology, smart Coolant Distribution Units and a century of cooling management expertise.
ECL’s Zacks Rank & Key Picks
Currently, ECL carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Medpace Holdings (MEDP - Free Report) , Intuitive Surgical (ISRG - Free Report) and Boston Scientific (BSX - Free Report) .
Medpace, currently carrying a Zacks Rank #2 (Buy), reported a third-quarter 2025 EPS of $3.86, which surpassed the Zacks Consensus Estimate by 10.29%. Revenues of $659.9 million beat the Zacks Consensus Estimate by 3.04%. You can see the complete list of today’s Zacks #1 Rank stocks here.
MEDP has an estimated earnings growth rate of 17.1% for 2025 compared with the industry’s 16.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 14.28%.
Intuitive Surgical, sporting a Zacks Rank #1 (Strong Buy) at present, posted a third-quarter 2025 adjusted EPS of $2.40, exceeding the Zacks Consensus Estimate by 20.6%. Revenues of $2.51 billion topped the Zacks Consensus Estimate by 3.9%.
ISRG has an estimated long-term earnings growth rate of 15.7% compared with the industry’s 11.9% growth. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 16.34%.
Boston Scientific, currently carrying a Zacks Rank #2, reported a third-quarter 2025 adjusted EPS of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%. Revenues of $5.07 billion outperformed the Zacks Consensus Estimate by 1.9%.
BSX has an estimated long-term earnings growth rate of 16.4% compared with the industry’s 13.5% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 7.36%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
ECL Boosts High-Tech Water Platform With Ovivo's Electronics Business
Key Takeaways
Ecolab (ECL - Free Report) recently closed its previously announced acquisition of Ovivo’s Electronics business, a fast-growing global provider of ultrapure water technologies used in semiconductor manufacturing. The deal meaningfully expands Ecolab’s presence in the high-tech water solutions space, positioning it to serve customers across the semiconductor value chain as demand accelerates from AI, advanced computing and data center investments.
By combining Ovivo Electronics’ ultrapure water expertise with Ecolab’s global water, digital and service capabilities, the company strengthens its water circularity offering in one of the most water-intensive industries.
Likely Trend of ECL Stock Following the News
Following the announcement, the company's shares traded flat in yesterday’s after-market trading. In the six-month period, shares have gained 0.6% against the industry’s 2.8% decline. The S&P 500 has gained 16.2% in the same time frame.
Over the long term, the Ovivo Electronics acquisition should strengthen Ecolab’s growth and margin profile by deepening its presence in the fast-growing semiconductor and AI ecosystem. Ultrapure water is mission-critical for chip manufacturing and combining Ovivo’s technologies with ECL’s global water, digital and service platform enables more comprehensive, end-to-end solutions, higher customer retention and recurring service revenues.
ECL currently has a market capitalization of $73.51 billion. In the last reported quarter, ECL delivered an earnings surprise of 0.49%.
Image Source: Zacks Investment Research
More on the Acquisition News
In August, Ecolab entered into a definitive agreement to acquire Ovivo’s Electronics business. Ovivo Electronics is expected to generate around $500 million in sales in 2025 and employs more than 900 people worldwide. ECL acquired the business for approximately $1.8 billion in cash, subject to customary adjustments. Strategically, the deal brings together Ovivo’s ultra-pure water capabilities with ECL’s established water solutions, digital technologies and global service network, enabling it to offer end-to-end circular water management solutions for microelectronics customers while helping reduce fresh water consumption and improve chip yield and quality.
Management highlighted that ultra-pure water is essential for advanced chip manufacturing, with a single semiconductor fab capable of consuming the annual drinking water needs of about 17 million people, underscoring the importance of sustainable water solutions. The acquisition is expected to more than double ECL’s global high-tech water growth engine, positioning the combined $800 million high-tech business for strong double-digit growth and attractive operating margins. Financially, the transaction is anticipated to be immediately accretive to sales growth, neutral to adjusted EPS in the first-year post-close, excluding roughly $45 million in non-cash amortization, and increasingly accretive through 2027 and beyond.
Favorable Industry Prospects for ECL
Per a report by Future Market Insights, the ultrapure water market is estimated to be valued at $10.9 billion in 2025 and projected to reach $31.1 billion by 2035, registering a CAGR of 11.1% over the forecast period.
The ultrapure water market is expanding steadily, owing to rising demand from industries where water purity is critical for operations such as semiconductor manufacturing, pharmaceuticals and power generation.
Other Recent Developments for ECL
In November, ECL expanded its data-center-focused portfolio with the launch of a fully integrated Cooling as a Service program designed to elevate cooling performance from site to chip. Arriving at a time when AI-driven workloads are rapidly intensifying demand on global data center infrastructure, the new offering combines Ecolab’s 3D TRASAR technology, smart Coolant Distribution Units and a century of cooling management expertise.
ECL’s Zacks Rank & Key Picks
Currently, ECL carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Medpace Holdings (MEDP - Free Report) , Intuitive Surgical (ISRG - Free Report) and Boston Scientific (BSX - Free Report) .
Medpace, currently carrying a Zacks Rank #2 (Buy), reported a third-quarter 2025 EPS of $3.86, which surpassed the Zacks Consensus Estimate by 10.29%. Revenues of $659.9 million beat the Zacks Consensus Estimate by 3.04%. You can see the complete list of today’s Zacks #1 Rank stocks here.
MEDP has an estimated earnings growth rate of 17.1% for 2025 compared with the industry’s 16.6% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 14.28%.
Intuitive Surgical, sporting a Zacks Rank #1 (Strong Buy) at present, posted a third-quarter 2025 adjusted EPS of $2.40, exceeding the Zacks Consensus Estimate by 20.6%. Revenues of $2.51 billion topped the Zacks Consensus Estimate by 3.9%.
ISRG has an estimated long-term earnings growth rate of 15.7% compared with the industry’s 11.9% growth. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 16.34%.
Boston Scientific, currently carrying a Zacks Rank #2, reported a third-quarter 2025 adjusted EPS of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%. Revenues of $5.07 billion outperformed the Zacks Consensus Estimate by 1.9%.
BSX has an estimated long-term earnings growth rate of 16.4% compared with the industry’s 13.5% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 7.36%.